Mesalazine Activates Adenosine Monophosphate-activated Protein Kinase: Implication in the Anti-inflammatory Activity of this Anti-colitic Drug | Bentham Science
Mechanism of Action of Aminosalicylates - YouTube
Drugs used in IBD and biological and immune therapy of IBD ” - ppt download
Treatment algorithm of active ulcerative colitis. 5-ASA,... | Download Scientific Diagram
Safety of 5-Aminosalicylic Acid Derivatives in Patients with Sensitivity to Acetylsalicylic Acid and Nonsteroidal Anti-inflammatory Drugs
Mesalazine - Wikipedia
Induction of Colonic Regulatory T Cells by Mesalamine by Activating the Aryl Hydrocarbon Receptor - ScienceDirect
Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology
Aspirin Mechanism of Action. | Download Scientific Diagram
Carcinogenesis in Ulcerative Colitis | IntechOpen
PPARgamma as a new therapeutic target in inflammatory bowel diseases. - Abstract - Europe PMC
Prokinetic Drugs A gastroprokinetic agent, gastrokinetic, or prokinetic, is a type of drug which enhances gastrointestinal motility by increasing the frequency. - ppt video online download
Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology
Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence - DESREUMAUX - 2006 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Clinical Pharmacology of 5-ASA Compounds in Inflammatory Bowel Disease - Gastroenterology Clinics
New therapeutic avenues in ulcerative colitis: thinking out of the box | Gut
IJMS | Free Full-Text | Mechanisms of Colorectal Cancer Prevention by Aspirin—A Literature Review and Perspective on the Role of COX-Dependent and -Independent Pathways | HTML
Frontiers | Aspirin: The Mechanism of Action Revisited in the Context of Pregnancy Complications | Immunology
A review on 5-aminosalicylic acid colon-targeted oral drug delivery systems - ScienceDirect
Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease - Allgayer - 2003 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Mesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1 - ScienceDirect
Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology
Drugs used in inflammatory bowel disease and biological and immune therapy of IBD Prof. Hanan Hagar Pharmacology Unit College of Medicine. - ppt download
DRUG TREATMENT OF INFLAMMATORY BOWEL DISEASE. Objectives Describe the mechanism of action, pharmacokinetics and adverse effects of drugs in IBD. - ppt download
Frontiers | Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases | Pharmacology
Mechanism of Action of Aminosalicylates
Ulcerative Colitis: Achieving and Maintaining Remission
